![Jonathan Yingling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Yingling
Hoofd Techniek/Wetenschap/O&O bij
ARCUS BIOSCIENCES, INC.
Profiel
Dr. Jonathan Yingling is a Chief Scientific Officer at Arcus Biosciences, Inc. Dr. Yingling was previously employed as a Chief Scientific Officer & Senior Vice President by Idera Pharmaceuticals, Inc., a Chief Scientific Officer by DNIB Unwind, Inc., a Vice President-Oncology Discovery by Bristol Myers Squibb Co., and a Vice President-Translational Science & Technology by Eli Lilly & Co. He received his undergraduate degree from The College of William & Mary and a doctorate degree from Duke University School of Medicine.
Actieve functies van Jonathan Yingling
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2020 |
Eerdere bekende functies van Jonathan Yingling
| Bedrijven | Functie | Einde |
|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Hoofd Techniek/Wetenschap/O&O | 31-01-2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-10-2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| DNIB UNWIND INC | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jonathan Yingling
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
61
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
